Asia, Latam Recalls Ordered For J&J's Cilest Birth-Control Drug
This article was originally published in PharmAsia News
Executive Summary
Johnson & Johnson ordered Asia, Latin America and Europe recalls of 32 million packages of its Cilest (ethinylinestradiol/norgestimate) oral contraceptive.